← back to search

Naoki Ishiguro

Aichi Developmental Disability Center · JP
Area of research
Rheumatology · Surgery
Research interest
Research interests include Rheumatoid Arthritis Research and Therapies, Spine and Intervertebral Disc Pathology, Cervical and Thoracic Myelopathy, and Scoliosis diagnosis and treatment.
h-index
80
citations
28,070
works
1,114
NIH funding
primary concept
email

Recent publications

Long-term safety and efficacy of filgotinib treatment for rheumatoid arthritis in Japanese patients naïve to MTX treatment (FINCH 3)
Modern Rheumatology 2022cited by 9position: middledoi
Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate : Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3)
Institutional Repositories DataBase (IRDB) 2022cited by 5position: middle
Efficacy, Safety, and Tolerability of ONO-4474, an Orally Available Pan-Tropomyosin Receptor Kinase Inhibitor, in Japanese Patients With Moderate to Severe Osteoarthritis of the Knee: A Randomized, Placebo-Controlled, Double-Blind, Parallel-Group Comparative Study.
2020cited by 6position: contributordoi
Effect of denosumab on Japanese patients with rheumatoid arthritis: a dose–response study of AMG 162 (Denosumab) in patients with RheumatoId arthritis on methotrexate to Validate inhibitory effect on bone Erosion (DRIVE)—a 12-month, multicentre, randomised, double-blind, placebo-controlled, phase II clinical trial
Annals of the Rheumatic Diseases 2016cited by 162position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Yoshiya Tanaka · Chukyo Hospital3 papers (2016–2022)Tsutomu Takeuchi · Keio University3 papers (2016–2022)Akira Kondo · Gilead Sciences (United States)2 papers (2022–2022)Zhaoyu Yin · Gilead Sciences (United States)2 papers (2022–2022) · 2 papers (2022–2022)René Westhovens · Universitair Ziekenhuis Leuven2 papers (2022–2022) · 2 papers (2022–2022)Beatrix Bartók · Gilead Sciences (United States)2 papers (2022–2022) · 2 papers (2022–2022) · 2 papers (2022–2022)Osvaldo Daniel Messina · Università Campus Bio-Medico2 papers (2022–2022)Gerd R Burmester · Humboldt-Universität zu Berlin2 papers (2022–2022)Tatsuya Atsumi · Hokkaido University2 papers (2022–2022)Alena Pechonkina · Gilead Sciences (United States)2 papers (2022–2022)Chantal Tasset · Galapagos (Belgium)2 papers (2022–2022)Koichi Amano · Okayama University2 papers (2022–2022)Mark C. Genovese · Palo Alto University1 papers (2022–2022)Ying Guo · Guangxi University1 papers (2022–2022)Qi Gong · San Francisco VA Medical Center1 papers (2022–2022) · 1 papers (2016–2016)